Highly purified cannabidiol ( <scp>CBD</scp> ) in <scp>CDKL5</scp> deficiency disorder ( <scp>CDD</scp> ): Open‐label prospective study

Marco Perulli, Alessia De Gioia, Federica Ruggiero, Federica Ascione, Chiara Porto, Elisa Musto, Valentina Massaroni, Maria Picilli, Maria Luigia Gambardella, Michela Quintiliani, Ilaria Contaldo, Chiara Veredice, Domenica Immacolata Battaglia

Open source

DOI: 10.1002/epi4.70213
Published: 2026-02-12
Container: Epilepsia Open
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/epi4.70213,
  title = {Highly purified cannabidiol (
                    <scp>CBD</scp>
                    ) in
                    <scp>CDKL5</scp>
                    deficiency disorder (
                    <scp>CDD</scp>
                    ): Open‐label prospective study},
  author = {Marco Perulli and Alessia De Gioia and Federica Ruggiero and Federica Ascione and Chiara Porto and Elisa Musto and Valentina Massaroni and Maria Picilli and Maria Luigia Gambardella and Michela Quintiliani and Ilaria Contaldo and Chiara Veredice and Domenica Immacolata Battaglia},
  year = {2026},
  journal = {Epilepsia Open},
  doi = {10.1002/epi4.70213},
  url = {https://doi.org/10.1002/epi4.70213}
}

RIS

TY  - JOUR
TI  - Highly purified cannabidiol (
                    <scp>CBD</scp>
                    ) in
                    <scp>CDKL5</scp>
                    deficiency disorder (
                    <scp>CDD</scp>
                    ): Open‐label prospective study
AU  - Marco Perulli
AU  - Alessia De Gioia
AU  - Federica Ruggiero
AU  - Federica Ascione
AU  - Chiara Porto
AU  - Elisa Musto
AU  - Valentina Massaroni
AU  - Maria Picilli
AU  - Maria Luigia Gambardella
AU  - Michela Quintiliani
AU  - Ilaria Contaldo
AU  - Chiara Veredice
AU  - Domenica Immacolata Battaglia
PY  - 2026
JO  - Epilepsia Open
DO  - 10.1002/epi4.70213
UR  - https://doi.org/10.1002/epi4.70213
ER  -

APA

Perulli, M., Gioia, A. D., Ruggiero, F., Ascione, F., Porto, C., Musto, E., Massaroni, V., Picilli, M., Gambardella, M. L., Quintiliani, M., Contaldo, I., Veredice, C., & Battaglia, D. I. (2026). Highly purified cannabidiol ( <scp>CBD</scp> ) in <scp>CDKL5</scp> deficiency disorder ( <scp>CDD</scp> ): Open‐label prospective study. Epilepsia Open. https://doi.org/10.1002/epi4.70213

Source records

crossref · retrieved 2026-09-26T09:09:00.719Z